Eduardo Miñambres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eduardo Miñambres has a total of 292 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Domínguez-Gil
Organización Nacional de Trasplantes, Madrid, Spain
11 shared publications - Alejandro Gonzalez Castro
Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
9 shared publications Elisabeth Coll
Organización Nacional de Trasplantes: Organizacion Nacional de Trasplantes
7 shared publicationsMaria Angeles Ballesteros
Transplant Coordination Unit and Service of Intensive Care, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain
7 shared publications- Maria Angeles Ballesteros
Trauma and Neurocritical ICU. Department of Intensive Care, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain
7 shared publications Borja Suberviola
Transplant Coordination Unit & Service of Intensive Care, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain
5 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Frontiers Media SA in Transplant International
- Vol. 39, 17755
Reply to Don’t forget to safeguard the lungs during DCD multi-organ retrieval! Early in situ oxygenated preservation matters
We read with interest the letter submitted by Jorda-Aragón et al (1) and appreciate their thoughtful comments. However, we do not agree with the authors' assertion that the lung has been relegated to a secondary role in the Bucharest consensus documents (2,3), which established standards for controlled donation after circulatory determination of death (cDCDD) in adults and provided specific recommendations regarding the use of normothermic regional perfusion (NRP) in this donor population. These consensus processes were not intended to provide detailed, organ-specific technical guidance, except where such guidance was directly relevant to the application of NRP. The management of lungs for transplantation in the context of both abdominal NRP (A-NRP) and thoracoabdominal NRP (TA-NRP) is appropriately addressed in the NRP consensus document.The authors' suggest that early lung ventilation, immediately after completion of the mandatory hands-off period and declaration of death, is essential to optimize lung graft preservation (1). We fully support measures aimed at achieving early optimal lung preservation. Indeed, there is international experience with combined lung recovery and A-NRP having been reported, including published protocols in which mechanical ventilation is resumed soon after death has been formally declared in combination with initiation of A-NRP (4-6). Conversely, concerns exist in some jurisdictions that the immediate resumption of cyclical ventilation could potentially be associated with restoration of effective cardiac activity and safety measures are required to delay the resumption of mechanical ventilation beyond the completion of the hands-off period.These protocols allow for immediate reintubation but require delay of lung insufflation until 10 minutes after the onset of mechanical asystole and cyclical ventilation only during the pulmonary flush at surgical retrieval (7,8).In the context of A-NRP, monitoring of the left radial artery during cDCDD is used as a simple means of detecting any restoration of effective cardiac activity and systemic circulation or the possibility of restoring cerebral perfusion due to inadequate occlusion of the thoracic aorta. Such an event would be readily identified by the appearance of a pulsatile arterial pressure waveform in the left radial artery in the event of restoration of effective cardiac activity, or by the appearance of non-pulsatile pressure in the left radial artery in the event of inadequate occlusion of the thoracic aorta (9,10).These differences highlight the importance of ongoing evaluation of post-mortem interventions and the publication of case series or incident sharing. As international clinical experience continues to accumulate, greater harmonization of practices across countries may become possible. However, the specific timing of the resumption of mechanical ventilation following the determination of death was not addressed during the Bucharest consensus deliberations and, consequently, no specific recommendation on this issue was made.We are aware of the lack of standardization in the combined recovery of the heart and lungs using TA-NRP. As the authors point out, the ESOT Bucharest Consensus explicitly acknowledges the potential risks of lung congestion and cardiac distension during TA-NRP. Left atrial venting, through the insertion of a venting catheter via the interatrial groove at the initiation of TA-NRP, has been proposed to prevent hydrostatic pulmonary edema (11). However, although this issue was discussed during the Consensus Conference, no consensus was reached among the panelists. Therefore, while acknowledging this concern, we cannot recommend this maneuver based on the findings of the Delphi process. As international experience with the simultaneous recovery of the heart and lungs using TA-NRP continues to grow, the technique may become increasingly standardized, allowing optimal preservation of all organs.
- 1 October 2026
- Published by Frontiers Media SA in Transplant International
- Vol. 39, 17755
Open AccessReply to Don’t forget to safeguard the lungs during DCD multi-organ retrieval! Early in situ oxygenated preservation matters
We read with interest the letter submitted by Jorda-Aragón et al (1) and appreciate their thoughtful comments. However, we do not agree with the authors' assertion that the lung has been relegated to a secondary role in the Bucharest consensus documents (2,3), which established standards for controlled donation after circulatory determination of death (cDCDD) in adults and provided specific recommendations regarding the use of normothermic regional perfusion (NRP) in this donor population. These consensus processes were not intended to provide detailed, organ-specific technical guidance, except where such guidance was directly relevant to the application of NRP. The management of lungs for transplantation in the context of both abdominal NRP (A-NRP) and thoracoabdominal NRP (TA-NRP) is appropriately addressed in the NRP consensus document.The authors' suggest that early lung ventilation, immediately after completion of the mandatory hands-off period and declaration of death, is essential to optimize lung graft preservation (1). We fully support measures aimed at achieving early optimal lung preservation. Indeed, there is international experience with combined lung recovery and A-NRP having been reported, including published protocols in which mechanical ventilation is resumed soon after death has been formally declared in combination with initiation of A-NRP (4-6). Conversely, concerns exist in some jurisdictions that the immediate resumption of cyclical ventilation could potentially be associated with restoration of effective cardiac activity and safety measures are required to delay the resumption of mechanical ventilation beyond the completion of the hands-off period.These protocols allow for immediate reintubation but require delay of lung insufflation until 10 minutes after the onset of mechanical asystole and cyclical ventilation only during the pulmonary flush at surgical retrieval (7,8).In the context of A-NRP, monitoring of the left radial artery during cDCDD is used as a simple means of detecting any restoration of effective cardiac activity and systemic circulation or the possibility of restoring cerebral perfusion due to inadequate occlusion of the thoracic aorta. Such an event would be readily identified by the appearance of a pulsatile arterial pressure waveform in the left radial artery in the event of restoration of effective cardiac activity, or by the appearance of non-pulsatile pressure in the left radial artery in the event of inadequate occlusion of the thoracic aorta (9,10).These differences highlight the importance of ongoing evaluation of post-mortem interventions and the publication of case series or incident sharing. As international clinical experience continues to accumulate, greater harmonization of practices across countries may become possible. However, the specific timing of the resumption of mechanical ventilation following the determination of death was not addressed during the Bucharest consensus deliberations and, consequently, no specific recommendation on this issue was made.We are aware of the lack of standardization in the combined recovery of the heart and lungs using TA-NRP. As the authors point out, the ESOT Bucharest Consensus explicitly acknowledges the potential risks of lung congestion and cardiac distension during TA-NRP. Left atrial venting, through the insertion of a venting catheter via the interatrial groove at the initiation of TA-NRP, has been proposed to prevent hydrostatic pulmonary edema (11). However, although this issue was discussed during the Consensus Conference, no consensus was reached among the panelists. Therefore, while acknowledging this concern, we cannot recommend this maneuver based on the findings of the Delphi process. As international experience with the simultaneous recovery of the heart and lungs using TA-NRP continues to grow, the technique may become increasingly standardized, allowing optimal preservation of all organs.
- 16 July 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (10) , 2419-2420
Reply to “Low blood pressure alone in the posterior brain circulation during thoraco-abdominal normothermic reperfusion does not assure brain circulatory arrest”
- 16 July 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (10) , 2419-2420
Reply to “Low blood pressure alone in the posterior brain circulation during thoraco-abdominal normothermic reperfusion does not assure brain circulatory arrest”
- 26 February 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1745-1754
Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death
- 26 February 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (7) , 1745-1754
Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death
- Open Access
- 10 April 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (5) , e1790
New Donor Selection Criteria Result in Optimal Outcomes of Kidneys from Uncontrolled Donation After the Circulatory Determination of Death
Background.: The aim of our study is to share our experience with uncontrolled donation after the circulatory determination of death (uDCDD) kidney transplantation and to propose updated donor selection criteria for uDCDD programs. Methods.: A prospective study comparing kidney recipients of grafts from local uDCDD donors with recipients of grafts from local standard criteria donors after the neurological determination of death (DNDD) between 2013 and 2024. Donor acceptance was determined using a combination of 3 factors: donor age, no-flow period, and warm ischemic time (WIT). Normothermic regional perfusion was the preservation method in uDCDD cases. Results.: The study included 43 kidney recipients from uDCDD donors and 80 controls. The median no-flow period was 10 min (interquartile range, 5–13), and the median WIT was 101 min (interquartile range, 86–118). The incidence of delayed graft function was significantly higher in the uDCDD group (46.5% versus 21.3%; P = 0.004), although no significant difference was observed in primary nonfunction rates (2.3% versus 0%; P = 0.35). Long-term outcomes, including serum creatinine levels and estimated glomerular filtration rate at 5 y, were similar in both groups. Graft survival rates at 1 y (95.3% versus 100%) and 5 y (92.1% versus 95%) showed no significant differences between the uDCDD and the DNDD groups. Multivariate analysis revealed that uDCDD kidney recipients did not have a higher risk of graft loss. Conclusions.: Kidney transplantation from uDCDD donors is a viable option, yielding outcomes comparable with those from standard DNDD donors. Strict donor selection criteria and efforts to minimize WIT are essential to achieving optimal long-term results.
- 10 April 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (5) , e1790
Open AccessNew Donor Selection Criteria Result in Optimal Outcomes of Kidneys from Uncontrolled Donation After the Circulatory Determination of Death
Background.: The aim of our study is to share our experience with uncontrolled donation after the circulatory determination of death (uDCDD) kidney transplantation and to propose updated donor selection criteria for uDCDD programs. Methods.: A prospective study comparing kidney recipients of grafts from local uDCDD donors with recipients of grafts from local standard criteria donors after the neurological determination of death (DNDD) between 2013 and 2024. Donor acceptance was determined using a combination of 3 factors: donor age, no-flow period, and warm ischemic time (WIT). Normothermic regional perfusion was the preservation method in uDCDD cases. Results.: The study included 43 kidney recipients from uDCDD donors and 80 controls. The median no-flow period was 10 min (interquartile range, 5–13), and the median WIT was 101 min (interquartile range, 86–118). The incidence of delayed graft function was significantly higher in the uDCDD group (46.5% versus 21.3%; P = 0.004), although no significant difference was observed in primary nonfunction rates (2.3% versus 0%; P = 0.35). Long-term outcomes, including serum creatinine levels and estimated glomerular filtration rate at 5 y, were similar in both groups. Graft survival rates at 1 y (95.3% versus 100%) and 5 y (92.1% versus 95%) showed no significant differences between the uDCDD and the DNDD groups. Multivariate analysis revealed that uDCDD kidney recipients did not have a higher risk of graft loss. Conclusions.: Kidney transplantation from uDCDD donors is a viable option, yielding outcomes comparable with those from standard DNDD donors. Strict donor selection criteria and efforts to minimize WIT are essential to achieving optimal long-term results.
- Top Cited PapersOpen Access
- 22 February 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (7) , 1526-1539
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain
- 22 February 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (7) , 1526-1539
Top Cited PapersOpen AccessDCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain
- Top Cited PapersOpen Access
- 20 September 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (2) , 213-221
Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study
- 20 September 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (2) , 213-221
Top Cited PapersOpen AccessMaintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study
- Open Access
- 30 May 2023
- Published by Springer Nature in Research Square
Maintaining the Permanence Principle of Death During Normothermic Regional Perfusion in Controlled Dcd: Results of a Prospective Clinical Study
Purpose The use of normothermic regional perfusion (NRP) in donation after the circulatory determination of death (DCD) is limited by concerns associated with the reestablishment of circulation after death declaration. The aim of this study is to confirm that certain technical maneuvers applied during NRP preclude circulation to the brain. Methods A non-randomized trial was performed at two Spanish centers. Consecutive adult controlled DCD donors were included. In abdominal NRP (A-NRP), the thoracic aorta was blocked with an intra-aortic occlusion balloon. In thoraco-abdominal NRP (TA-NRP), the arch vessels were clamped and the cephalad ends vented to the atmosphere. Blood from the vented arch vessels drained to the thorax. The mean intracerebral arterial blood pressure (ICBP) was invasively measured at the circle of Willis. Results Ten cDCD donors subject to A-NRP (n = 8) and TA-NRP (n = 2) were included. Mean ICBP and mean blood pressure at the thoracic and the abdominal aorta during the circulatory arrest were 16.9 (SD:3.0), 17.2 (SD:3.0) and 17.6 (SD:4.4), respectively. When A-NRP was started, pressure at the abdominal aorta increased to 49.9 (SD:12.5) mmHg, while the ICBP remained unchanged. When TA-NRP was initiated, pressure at the thoracic aorta reached values of 70.5 (SD:17.7) mmHg, but the ICBP remained unmodified. Registered values of ICBP during NRP were 10 mmHg. Conclusion Appropriate technical measures applied during NRP preclude circulation to the brain in DCD procedures. This study can help to expand NRP, respecting the dead donor rule and increasing the number and quality of organs available for transplantation.
- 30 May 2023
- Published by Springer Nature in Research Square
Open AccessMaintaining the Permanence Principle of Death During Normothermic Regional Perfusion in Controlled Dcd: Results of a Prospective Clinical Study
Purpose The use of normothermic regional perfusion (NRP) in donation after the circulatory determination of death (DCD) is limited by concerns associated with the reestablishment of circulation after death declaration. The aim of this study is to confirm that certain technical maneuvers applied during NRP preclude circulation to the brain. Methods A non-randomized trial was performed at two Spanish centers. Consecutive adult controlled DCD donors were included. In abdominal NRP (A-NRP), the thoracic aorta was blocked with an intra-aortic occlusion balloon. In thoraco-abdominal NRP (TA-NRP), the arch vessels were clamped and the cephalad ends vented to the atmosphere. Blood from the vented arch vessels drained to the thorax. The mean intracerebral arterial blood pressure (ICBP) was invasively measured at the circle of Willis. Results Ten cDCD donors subject to A-NRP (n = 8) and TA-NRP (n = 2) were included. Mean ICBP and mean blood pressure at the thoracic and the abdominal aorta during the circulatory arrest were 16.9 (SD:3.0), 17.2 (SD:3.0) and 17.6 (SD:4.4), respectively. When A-NRP was started, pressure at the abdominal aorta increased to 49.9 (SD:12.5) mmHg, while the ICBP remained unchanged. When TA-NRP was initiated, pressure at the thoracic aorta reached values of 70.5 (SD:17.7) mmHg, but the ICBP remained unmodified. Registered values of ICBP during NRP were 10 mmHg. Conclusion Appropriate technical measures applied during NRP preclude circulation to the brain in DCD procedures. This study can help to expand NRP, respecting the dead donor rule and increasing the number and quality of organs available for transplantation.
- Open Access
- 24 April 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (7) , 996-1008
Outcomes of lung and liver transplantation after simultaneous recovery using abdominal normothermic regional perfusion in donors after the circulatory determination of death versus donors after brain death
- 24 April 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (7) , 996-1008
Open AccessOutcomes of lung and liver transplantation after simultaneous recovery using abdominal normothermic regional perfusion in donors after the circulatory determination of death versus donors after brain death
- 15 November 2022
- Published by Elsevier in Transplantation Proceedings
- Vol. 54 (9) , 2406
Preface
- 26 October 2022
- Published by Wiley in Clinical Transplantation
- Vol. 37 (1) , e14832
Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience
Introduction: Azithromycin (AZI) may be an effective immune modulator in lung transplant (LT) recipients, and can decrease chronic lung allograft dysfunction (CLAD) rates, the leading cause of mortality after the 1st year post‐LT. The aim of the study is to assess the effect of AZI initiation and its timing on the incidence and severity of CLAD in LT recipients.Methods: Single‐center retrospective study, including LT recipients from 01/01/2011 to 30/06/2020. Four groups were established: those who started AZI at the 3rd week post‐LT (group A), those who received AZI later than the 3rd week post‐LT and had preserved FEV1 (B), those who did not receive AZI (C) and those who started AZI due to a decline in FEV1 (D). The dosage of AZI prescribed was 250 mg three times per week. CLAD was defined and graduated according to the 2019 ISHLT criteria.Results: We included 358 LT recipients: 139 (38.83%) were in group A, 94 (26.25%) in group B, 91 (25.42%) in group C, and 34 (9.50%) in group D. Group A experienced the lowest CLAD incidence and severity at 1 (p = .01), 3 (p < .001), and 5 years post‐LT, followed by Group B. Groups C and D experienced a higher incidence and severity of CLAD (p = .015). Initiation of AZI prior to FEV1 decline (Groups A and B) proved to be protective against CLAD after adjusting for differences between the treatment groups.Conclusions: Early initiation of AZI in LT recipients could have a role in decreasing the incidence and severity of CLAD. In addition, as long as FEV1 is preserved, initiating AZI at any time could also be useful to prevent the incidence of CLAD and reduce its severity.
- 26 October 2022
- Published by Wiley in Clinical Transplantation
- Vol. 37 (1) , e14832
Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience
Introduction: Azithromycin (AZI) may be an effective immune modulator in lung transplant (LT) recipients, and can decrease chronic lung allograft dysfunction (CLAD) rates, the leading cause of mortality after the 1st year post‐LT. The aim of the study is to assess the effect of AZI initiation and its timing on the incidence and severity of CLAD in LT recipients.Methods: Single‐center retrospective study, including LT recipients from 01/01/2011 to 30/06/2020. Four groups were established: those who started AZI at the 3rd week post‐LT (group A), those who received AZI later than the 3rd week post‐LT and had preserved FEV1 (B), those who did not receive AZI (C) and those who started AZI due to a decline in FEV1 (D). The dosage of AZI prescribed was 250 mg three times per week. CLAD was defined and graduated according to the 2019 ISHLT criteria.Results: We included 358 LT recipients: 139 (38.83%) were in group A, 94 (26.25%) in group B, 91 (25.42%) in group C, and 34 (9.50%) in group D. Group A experienced the lowest CLAD incidence and severity at 1 (p = .01), 3 (p < .001), and 5 years post‐LT, followed by Group B. Groups C and D experienced a higher incidence and severity of CLAD (p = .015). Initiation of AZI prior to FEV1 decline (Groups A and B) proved to be protective against CLAD after adjusting for differences between the treatment groups.Conclusions: Early initiation of AZI in LT recipients could have a role in decreasing the incidence and severity of CLAD. In addition, as long as FEV1 is preserved, initiating AZI at any time could also be useful to prevent the incidence of CLAD and reduce its severity.